Peers of Artiva Biotherapeutics Inc (ARTV)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
-432.27x
As of Mar 28, 2025
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Mar 28, 2025 | -432.27x |
| Mar 27, 2025 | -395.50x |
| Mar 26, 2025 | -385.82x |
| Mar 25, 2025 | -351.95x |
| Mar 24, 2025 | -359.69x |
| Mar 21, 2025 | -324.85x |
| Mar 20, 2025 | -347.11x |
| Mar 19, 2025 | -308.40x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison